China has launched its first multi-centre clinical trial for brain-computer interface technology in neurocritical care, marking a major expansion of medical applications beyond motor and cognitive rehabilitation. This is reported by
China Daily, a partner of TV BRICS.
The research focuses on conditions such as hydrocephalus, a complication affecting up to 50 per cent of patients with cerebral haemorrhage, which often faces prolonged diagnosis and high misdiagnosis rates. Using domestically developed BCI devices with independently designed chips, scientists have reduced the time required to diagnose hydrocephalus from two to three days to just 30 minutes, while improving accuracy.
The research aims to address severe neurological conditions such as hydrocephalus, which affects up to half of patients with cerebral haemorrhage and is often misdiagnosed.
New domestically developed BCI devices with independently designed chips have reduced diagnosis time from several days to just 30 minutes while improving accuracy.
According to experts, the project aims to establish Chinese technologies, standards and protocols for precise management of neurocritical conditions, paving the way for wider clinical adoption. The team also demonstrated next-generation wearable EEG devices for real-time monitoring of neurological health.
Photo:
iStock / Thinkhubstudio
Самые
актуальные новости стран БРИКС https://tvbrics.com